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The STEll gene of Saccbaromyces cerevisiae is one of several genes required for mating between two haploid 
cell types of this yeast. Its product is required for response to a signal that causes arrest of the mitotic cell cycle 
in the Gi phase and induction of mating-type-specific genes. The nucleotide sequence of the STEll gene was 
determined. The predicted amino acid sequence shows homology to the protein kinase family. We demonstrate 
that the STEll product has kinase catalytic activity and that this activity is required for its in vivo functions. 
[Key Words: Protein kinase; yeast mating response pathway; gene expression; epitope-tagging] 
Received June 22, 1990; revised version accepted August 28, 1990. 
The yeast Saccharomyces cerevisiae is an experimen-
tally accessible eukaryotic organism for the study of 
events controlling cell-type determination and cell com-
munication. The a and a haploid cells of this yeast are 
able to mate with each other to form an a/a diploid cell 
that is mating incompetent. Recognition between the a 
and a cell types initiates and coordinates events that are 
a precondition for cell fusion. This recognition is me-
diated by the peptide pheromones, a- and a-factor, which 
are characteristic of each cell type and their respective 
receptors (for review, see Cross et al. 1988; Herskowitz 
1989). The signal generated by the interaction between 
receptor and mating pheromone causes transcriptional 
induction of genes required for mating, as well as for ar-
rest of the mitotic cell cycle in the Gi phase. 
It appears that all components necessary for the re-
sponse elicited by pheromone-receptor binding are the 
same in both cell types (Bender and Sprague 1986; Na-
kayama et al. 1987). Genetic approaches to dissect the 
signal transduction pathway have led to the identifica-
tion of several genes {GPAl/SCGl, STE4, STE5, STE7, 
STEll, STE12, STE18, and FUS3] that specify, directly or 
indirectly, components of the signal pathway (Hartwell 
1980; Dietzel and Kurjan 1987; Miyajima et al. 1987; 
Jahng et al. 1988; Nakayama et al. 1988; Whiteway et al. 
1989; Elion et al. 1990). Three of the genes {GPAl/ 
SCGl, STE4, and STE18] were found to encode proteins 
homologous to the a-, p-, and -y-subunits of mammalian 
G protein (Dietzel and Kurjan 1987; Miyajima et al. 
1987; Jahng et al. 1988; Whiteway et al. 1989). Various 
observations suggest a model for signal transmission in 
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which pheromone binding to receptor promotes the ex-
change of GDP for GTP, resulting in dissociation of the 
3,-y-complex from the GTP bound a-subunit. It appears 
that free 3,7-complex transmits the signal (Blinder et al. 
1989; Cole et al. 1990; Nomoto et al. 1990; Whiteway et 
al. 1990). Little is known about the steps in the signal 
pathway after the G-protein, except that the STE12 tran-
scription factor has been implicated as a possible nuclear 
target for the signal (Dolan et al. 1989; Errede and Am-
merer 1989). 
We have begun investigations to determine what 
fimction the STEll product has in the pheromone re-
sponse pathway. Mutation of the STEll gene prevents 
mating and responses to pheromone, including arrest of 
the mitotic cell cycle in the Gi phase and induction of 
cell-type-specific gene expression (Hartwell 1980; 
McCaffrey et al. 1987; Trueheart et al. 1987). The STEll 
gene product is also required for basal expression from a 
cell-type-specific activator sequence (Errede et al. 1981). 
It has been difficult to place the point of action for 
STEll in the signal pathway, because in its absence 
there is a reduction in the basal-level expression of the 
pheromones (15- to 100-fold), receptors (5-fold), and G-
protein a-subunit (2-fold) (Fields et al. 1988; Nakayama 
et al. 1988). However, we can infer that its function is 
required for signal transmission after the G-protein be-
cause stell mutants block the constitutive Gi arrest 
caused by loss of function of the G-protein a-subunit 
(Nakayama et al. 1988). In this study we provide evi-
dence of a STEll-dependent protein phosphorylation. 
This biochemical evidence supports the view that 
STEll is a protein kinase. In vivo analysis of a STEll 
catalytic residue substitution mutation supports the 
view that its kinase activity is required for its function 
in the mating response pathway. 
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Results 
STEll nucleotide sequence 
We determined the nucleotide sequence of the STEll 
gene. The 3.1-kb Hindill-Clal interval (Fig. lA, a) from 
the plasmid pSTEl 1.1 was used for sequence determina-
tion (Chaleff and Tatchell 1985). We report 2578 nucleo-
tides of sequence from this interval for which we have 
data on both strands (Fig. 2). The DNA sequence was 
translated in all six frames. The longest open reading 
frame (ORF) extends from position 32 to position 2266, 
where it terminates with a TGA translation termination 
codon. No consensus sequences for RNA splice sites in 
yeast were detected (Langford and Gallwitz 1983). 
STEll mRNA 
The 5' end of the STEll mRNA was determined by SI 
analysis. The major STEll transcript maps to position 
86 or 87 with minor transcripts mapping to positions 59 
1 kb 
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Figure 1. Representation of the STEll locus and STEll 
plasmids. [A] The 4.6-kb BamHl-Xhol fragment from pSTEU.l 
is shown (Chaleff and Tatchell 1985). The open box delimits 
the STEll protein-coding region. Bars indicate fragments a-g 
used to manipulate STEll as described in the text. The Sphl 
site indicated on bars c and d comes from polylinker sequences 
flanking STEll in pNC192 or pNC251. (B) The plasmid 
pNC192 contains the STEll gene and its own promoter. The 
plasmid pNC251 contains the STEll gene imder control of the 
GAL1,10 promoter. The ampicillin-resistance gene (ap'), M13 
origin of replication (M13 ori), and yeast components are indi-
cated. The position of the myc epitope tag in plasmids pNC212 
and pNC245 is also indicated. Restriction sites: (A) Accl; (B) 
BamHl, (C) CM, (E) £coRI; (H) Hindlll; (K) Kpnl, (N) Ncol; (P) 
PstI; (Sp) SphI; (X) Xhol; (Xb) Xbal. 
or 60, 68 or 69, 91 or 92, and 98 or 99. The signal from 
the protected DNA probe was proportional to the 
amoimt of STEll •*• RNA in the reaction (Fig. 3A, lanes 1 
and 2). No signal was observed for reactions performed 
with RNA from the isogenic stell^ strain (Fig. 3A, lane 
3) or when RNA was absent from the nuclease digestion 
reactions (Fig. 3A, lane 4). We found no difference in 5' 
map positions or abundance of STEll mRNA prepared 
from either pheromone-treated (a-factor) cultures or un-
treated cultures (Fig. 3B). A TATA-box-like sequence 
(nucleotide positions 42-47) is present 40 nucleotides 
upstream from the major mRNA 5' map position. A se-
quence similar to the tripartite transcription termina-
tion control consensus sequence (TAG/TATGT/TTT) 
identified by Zaret and Sherman (1982) is present in the 
STEll sequence between nucleotides 2352 and 2390 
(Fig. 2). On the basis of the 5' map position and the in-
ferred 3' end, the predicted STEll transcription unit is 
close to the observed 2.4-kb size for the STEll RNA 
(Chaleff and Tatchell 1985). 
STEl 1 translation product 
The STEll ORF contains three ATG codons near the 5' 
end (located at nucleotide positions 53, 86, and 116; Fig. 
2). None of these occurs in a sequence context that is a 
good match to the consensus associated with transla-
tional initiator regions in yeast (Cigan and Donahue 
1987). The 5' map positions of STEll mRNAs made it 
possible that the ATG codons at positions 86 and/or 116 
could be used for initiation of the STEll primary trans-
lation product. Frameshift mutations were made to de-
termine which of these codons is necessary for a func-
tional STEl 1 product. The rationale for this approach is 
that a nucleotide insertion or deletion before the initia-
tion codon should not cause a mutant phenotype, 
whereas an insertion or deletion after the initiation 
ATG should result in a stel 1 null mutation. 
Two frameshift mutations were made. One mutation 
was an insertion of a single thymidine after nucleotide 
position 100 (between ATG codons at positions 86 and 
116). The other mutation was a deletion of a single 
guanine residue at nucleotide position 377 (after the 
ATG codon at position 116). Plasmids carrying the dif-
ferent STEll frameshift mutations were used to trans-
form a yeast strain with a complete stell deletion 
(E929-6C-5). Function of the different STEll frameshift 
mutations was assessed by whether the transformed 
strains were able to mate with a suitable tester strain. A 
nucleotide inserted after the ATG at position 86 resulted 
in a STEll product that is functional. In contrast, a 
single nucleotide deletion after the ATG at position 116 
resulted in a nonfunctional stell allele. These results, 
together with the 5' mRNA mapping experiments, are 
consistent with translation initiating from the first 
AUG in the major STEll mRNA (Fig. 2). The STEll 
translation product predicted in this case begins with 
the methionine coded for by the ATG at nucleotide po-
sition 116. The predicted STEll protein is 717 amino 
acids in length with a calculated molecular size of 80 
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Figure 2. Nucleotide and predicted protein sequence of the STEll gene. The nucleotide sequence of the coding strand is shown. The 
amino acid sequence for the complete ORF (nucleotide positions 32-2266) is shown below the nucleotide sequence. The initiating 
methionine (codon positions 116-118) for the predicted protein is underlined. A consensus TATA element (TATTTA) at nucleotide 
positions 42-47 is overlined. The 5' map positions for the STEll mRNA are denoted by asterisks (*) above the nucleotide sequence at 
positions 59 or 60, 68 or 69, 86 or 87, 91 or 92, and 98 or 99. The transcription termination control sequence (TAG/TATCT/TTT) 
between nucleotides 2352 and 2390 is underlined. Certain restriction sites are indicated: Hindlll (positions 1 and 1205), Accl (posi-
tions 101 and 2038), CM (position 440), £coRI (position 445), Pstl (position 2234), and JVcoI (position 2243). 
kD. These data do not indicate whether the AUG at po-
sition 86 could be used in the case of the minor mRNAs 
that map to nucleotide positions 59 or 60 and 68 or 69. 
Even if this longer translation product is made, it is not 
an essential species for STEll fimction because the 
frameshift mutation at nucleotide position 100 has no 
effect on mating ability. The position 100 frameshift 
mutation similarly rules out the possibility that a STEl 1 
product initiating with the ATG codon at position 53 
could be essential for mating. 
The predicted STEll protein is related to protein 
kinases 
The FASTA algorithm of Pearson and Lipman (1988) was 
used to compare the predicted STEll protein to the 
NBRF protein data base (Release 17, January 1989). The 
search revealed that the carboxy-terminal region (amino 
acid positions 413-717) of the predicted STEll protein 
shows striking homology to the catalytic domain of pro-
tein kinases. The STEll kinase domain has the 15-
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Figure 3. STEll 5' mRNA map positions as determined by SI 
analysis. [A] (Lanes 1 and 2) Protected products from SI nu-
clease digestion reactions using 50 |xg and 20 ixg of total RNA 
from STEll + strain E929-6C; (lane 3) control reaction using 50 
^lg of total RNA from stellA strain E929-6C-20; (lane 4] mock 
reaction with no RNA. RNAs were hybridized to the 200-nu-
cleotide probe prepared with oligonucleotide STE1L75 (Table 
2). (B) (Lanes STEll*] Protected products from SI nuclease di-
gestion reactions using 30 |xg of RNA isolated from cultures of 
STEl 1 + strain E929-6C either without a-factor (-) or after 2-hr 
exposure to 5 \iM a-factor ( + ); (lane stellA] control reaction 
using 30 |jLm of RNA prepared from stell^ strain E929-6C-5. 
RNAs were hybridized to the 1 lOO-nucleotide probe prepared 
with oHgonucleotide STEll.18 (Table 2). Lanes A, C, G, and T 
in A and B depict dideoxy sequencing products using either la-
beled oligonucleotide STEl 1.75 or STEl 1.18, respectively, as a 
primer and pNC193 DNA as template. These ladders show the 
nucleotide sequence of the noncoding strand. 
amino-acid residues that are conserved in the catalytic 
domain for at least 62 of the 65 protein kinases com-
pared by Hanks et al. (1988; Fig. 4). STEll has amino 
acid sequences in subdomains VI (DIKGAN) and VIII 
(GSVFWMSPE) with high similarity to the sequences 
DLKPEN and GT/SXXY/PXAPE, respectively, which are 
indicators of the serine/threonine family of protein ki-
nases (Hanks et al. 1988). 
An alignment of the STEl 1 kinase catalytic domain 
was made with that of the three other predicted protein 
kinases (STE7, KSSl, and FUS3), which have roles in the 
mating response pathway (Fig. 4) (Teague et al. 1986; 
Courchesne et al. 1989; Elion et al. 1990). The alignment 
indicates that STEl I is not more closely related to this 
group than to other protein kinases. Outside of the 15 
conserved residues characteristic of protein kinases, 
there are only 18 additional residues conserved among 
this group. STEl 1 is notably more similar to STE7 in the 
region of subdomains IV and V (38% identity) than to 
FUS3 or KSSl (12% identity to each). When the entire 
catalytic domain is compared^ STEl 1 is not significantly 
more similar to STE7 than to the other kinases. For the 
catalytic domain overlap region of 255 amino acids, the 
STEll protein showed 27% identity to STE7, 24% iden-
tity to FUS3, and 22% identity to KSSl. This is in con-
trast to the KSSl and FUS3 protein kinases, which are 
more closely related to each other (54% identity) than to 
other protein kinases. 
Immunological detection of STm 
We fused the coding sequence of a known epitope to the 
STEll gene to allow detection of the STEll product. 
The (phosen epitope consisted of 10 amino acids from 
human c-myc for which a specific monoclonal antibody 
(Mycl-9E10) was available (Evan et al. 1985; Munro and 
Pelkam 1987). An in-frame fusion of the epitope-coding 
fragment was made after codon 717 of STEll. The re-
sulting fusion product, designated STEllM, added an 
11-amino-acid peptide (EQKLISEEDLN) to the carboxyl 
terminus of the normal STEll protein. The STEllM al-
lele carried on a centromeric plasmid (pNC2I2) was 
functional when tested for complementation of the 
mating defect caused by a stell deletion in the recipient 
strain (E929-6C-5). 
We established that the monoclonal antibody 
Mycl-9E10 specifically detected the tagged STEIIM 
protein produced in yeast by immunoblot analysis (data 
not shown). Because of the low abundance of the 
STEllM protein, this detection required enrichment of 
the protein by fractionation of significant amounts of 
extract. To simplify detection procedures and biochem-
ical analyses described below, we overproduced the 
STEllM protein by placing the fusion gene under con-
trol of the GALIJO promoter (Fig. IB, pNC245). An 
analogous GALlJO-STEll construction (Fig. IB, 
pNC251) was made so that we would have a control for 
overproduction of STEl I protein in a form that does not 
react with the Mycl-9E10 antibody. The overproduced 
STEllM protein was easily detected by immunoblot 
analysis of extracts fractionated by SDS-PAGE (Fig. 5, 
STEllM). Under the same conditions, no yeast protein 
was detected using the control extract (Fig. 5, STEll) or 
with extract from yeast with a complete stel 1 deletion 
(Fig. 5, no STEll). The Mycl-9E10 antibodies also al-
lowed specific detection of the STEllM protein by im-
munoprecipitation (see below). 
STEl 1 kinase domain mutation 
An in vitro immune complex assay would allow us to 
determine whether the STEll gene product is a protein 
kinase (CoUett and Erikson 1978). We wanted to have a 
catalytically inactive protein available as a negative con-
trol to establish whether any protein phosphorylation 
observed in this assay was due to STEl 1 activity. The 
lysine at STEll position 444 corresponds to the con-
served lysine that is essential for catalytic activity of 
known protein kinases (Hanks et al. 1988 and references 
therein). We constructed an arginine substitution muta-
tion at lysine 444 of STEllM by site-directed muta-
genesis. This mutation was chosen because an arginine 
substitution at the analogous position of other protein 
kinases has been shown to abolish kinase catalytic ac-
tivity (Booher and Beach 1986; Celenza and Carlson 
1989). Moreover, the arginine substitution is conserva-
tive and not expected to cause instability of the resulting 
protein. 
The STEllM-R*^ protein was expressed from the 
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Figuie 4. Alignment of the conserved protein kinase domain of STEl 1 with STE7, FUSS, and KSSl. Arabic numerals at the beginning 
of each line specify the amino acid position for each protein. Roman numerals beneath the sequences refer to subdomains of the 
protein kinase catalytic domain. The protein alignments and subdomain designations follow the criteria described in Hanks et al. 
(1988). Residues conserved among the four kinases are shown below the protein sequences. Those residues conserved in 62 of the 65 
kinases compared in Hanks et al. (1988) are underlined. The sequences are STEll (Fig. 2], STE7 (Teague et al. 1986), FUS3 (Ehon et al. 
1990), and KSSl (Courchesne et al. 1989). 
GAL1,10 promoter (pNC245-R444) in a stell deletion 
yeast strain (E929-6C-5). The yeast strain that expresses 
the STEIIM-R'*^ protein was not able to mate with an 
appropriate tester strain. We showed that the same 
amount of the STEllM (lane 5) and STEllM-R'^^ (lane 
3) proteins were present in immune complexes from 
equivalent amounts of corresponding yeast extracts (Fig. 
6A). No yeast protein was detected with the control im-
mune complex performed with the untagged STEl 1 pro-
tein (Fig. 6A, lane 1). These results confirm our expecta-
tions (1) that the arginine substitution protein is non-
functional and (2) that it is stable. 
In vitro kinase assays 
Kinase assays were performed directly on immune com-
plexes prior to fractionation and blot analysis of the im-
mune complex proteins (see Fig. 6A). An autoradiograph 
of the immunoblot detected those proteins present in 
the immune complex that were ^^P-phosphorylated 
during the kinase reaction. The autoradiograph shows 
that a number of phosphoproteins of varying size were 
generated during assays with all immtme complexes 
(Fig. 6C, lanes 1, 3, and 5). Notably, phosphoproteins 
were present at the position of the STEl IM or STEl IM-
R^^ proteins (Fig. 6C, lanes 5 and 3). There was no phos-
phoprotein at this position in the control with the un-
tagged STEll protein (Fig. 6C, lane 1). These results in-
dicate that one or more contaminating kinases are 
nonspecifically adsorbed with the immune complexes 
and that both the STEllM and STEllM-R'^ proteins 
serve as a substrate. Unfortunately, this result precludes 
any conclusion as to whether STEll undergoes auto-
phosphorylation. Nonetheless, the autoradiograph pro-
vided evidence for a STEll-dependent phosphorylation. 
A 78-kD phosphoprotein (p78) was observed among the 
fractionated proteins from the immune complex with 
the functional STEllM but not from the complex with 
the mutant STEllM-R'^ protein (Fig. 6C, lanes 5 and 3). 
It is most likely that the p78 phosphoprotein observed 
in this assay is an endogenous yeast protein that copre-
cipitates with STEll. First, it is present whether im-
mune complexes are adsorbed with protein A-Sepha-
rose beads or Staphlyococcus aureus cells (data not 
shown). Second, it does not appear to be a protein that 
cross-reacts with the Mycl-9E10 antibodies because it is 
not observed on immunoblots of yeast proteins (Figs. 5B 
and 6A). The presence of p78 has been inferred only from 
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Figure 5. Immunological detection of the STEl IM protein. [A] 
Protein extract was prepared from a stall A strain (E929-6C-20) 
expressing STEll (pNC251), STEllM (pNC245), or no STEll 
(no plasmid). Each extract (100 |xg) was separated by SDS-gel 
electrophoresis and stained with Coomassie blue. Molecular 
weight standards are myosin, rabbit muscle phosphorylase b, 
bovine serum albumin, and hen egg white ovalbumin. [B] Im-
munoblot showing duplicates of samples in A. An arrow indi-
cates the position of the STEl IM protein. 
its appearance as a phosphoprotein in the protein kinase 
assay. We were unable to detect p78 directly by using 
immune precipitates prepared from ^^S-labeled protein 
extracts or by silver stain procedures (data not shown). 
Therefore, we could not directly rule out the possibility 
that p78 is a yeast protein whose expression might be 
dependent on a functional STEll. For this reason addi-
tional experiments were performed to ensure that p78 
was present in both the STEllM and STEllM-R*^ ex-
tracts used for immune complex formation. 
An immune complex assay was performed with 
STEll extract that had been mixed with STEllM-R*^ 
extract. In this experiment, the STEll extract would 
supply the 78-kD polypeptide for coprecipitation with 
the nonfunctional but immune-reactive STEllM-R'^ 
protein. Even though p78 was present in the mixed ex-
tract, it was not observed as a phosphoprotein with the 
nonfunctional STEllM-R'^ immune complex kinase 
reaction (Fig. 6C, lane 2). The p78 phosphoprotein was 
observed in the control experiment where STEl 1 extract 
was mixed with STEllM extract (Fig. 6C, lane 4). This 
control provides evidence that the STEl 1 extract did not 
inadvertently inhibit phosphorylation of p78 in the 
mixing experiment. 
A second set of experiments took advantage of the 
knowledge that there are no known genes whose expres-
sions are STEll-dependent without also being depen-
dent on the STE12 transcription factor (Errede et al. 
1981; Fields et al. 1988). If we establish that p78 is 
present in a stel2 deletion strain, we can rule out the 
possibility that p78 expression is STEll-dependent with 
reasonable assurance. Immune complex kinase assays 
were done with extracts prepared from a stel2 deletion 
strain (E929-6C-7) expressing either the STEllM or the 
STEllM-R*^ protein. Analysis of the fractionated im-
mune complex proteins from these assays showed that 
equal amounts of the STEllM and the STEllM-R*^ 
proteins were present (Fig. 6B, lanes 1 and 2). The p78 
phosphoprotein was observed for kinase reactions with 
the normal STEl IM protein (Fig. 6D, lane 2). This result 
provides direct evidence that expression of p78 is not de-
pendent on the STEl2 transcription factor and, by infer-
ence, is independent of STEll function. Yet p78 is not 
observed as a phosphoprotein for the immune complex 
assay with the kinase domain mutant STEl IM-R"^ pro-
tein (Fig. 6D, lane 1). It should be noted that the func-
tional but untagged STEll protein is expressed from the 
genome in the stel2 deletion strain used here. There-
fore, p78 is present in this extract regardless of the de-
duction that p78 expression is independent of STEll 
function. By two independent methods, we have ensured 
the presence of p78 but have not observed it as a phos-
phoprotein in kinase assays with the nonfunctional 
STEllM-R**^ protein. This result establishes that phos-
phorylation of p78 is STEll-dependent and provides bio-
chemical support for the view that STEll is a protein 
kinase. 
Protein kinases require a divalent cation for activity, 
and different kinases have different cation specificities. 
We investigated the divalent cation requirement for 
STEll kinase activity. Parallel immune complex assays 
were performed in the presence of 5 mM Mg^+, 5 mM 
Mn^+, 5 mM Câ "̂ , or 5 mM Zn+. Autoradiographs of the 
SDS-PAGE-fractionated proteins were compared vi-
sually for the presence and intensity of the signal that 
corresponds to the 78-kD polypeptide (data not shown). 
Mn̂ "*̂  appeared to be the preferred ion for kinase ac-
tivity, followed by Mg^+ and Zn^+. Ca^+ did not support 
any STEll catalytic activity. 
STEll kinase activity is not regulated by pheromone 
induction and is not restricted to the mating-
competent cell types 
The STEll gene product is required for mating and for 
response to pheromone. It is not essential for other cel-
lular processes because cells with a complete deletion of 
the gene are viable. Therefore, STEll function appears 
to be very specific, and one might expect that its expres-
sion or activity could be restricted to the cell types and 
stages where its action is required. It has already been 
shown that STEll mRNA is present in all cell types 
(Chaleff and Tatchell 1985). We have shown that STEll 
mRNA is not increased in abundance when cells are 
treated with pheromone (Fig. 3B). These results indicate 
that STEll expression is not regulated by the steady-
state abundance of its mRNA. 
Immune complex kinase assays were performed to in-
vestigate the possibility that STEll kinase activity may 
be enhanced or repressed under pheromone-inducing 
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Figure 6. Immune complex kinase assays. {A and B] Immunoblots of immune complexes formed with Mycl-9E10 antibody and 
protein extracts as specified below. An arrow indicates the position of the STEl IM and STEl IM-R*** proteins. Asterisks (*) show the 
positions of IgG(H + L) and IgG(H). (C and D) Autoradiographs of the immunoblots in A and B, respectively. The upper arrow indicates 
the position of phosphorylated STEUM-R"^ and STEUM; the lower arrow indicates the position of the phosphorylated 78-kD pro-
tein p78. {A and C) Protein extracts from transformed stellA (E929-6C-5) strains as follows: (Lane 1] STEll (pNC251|; (lane 2) STEll 
(pNC251) mixed with STEllM-R-^ (pNC245-R444); (lane 3] STEllM-R'^ (pNC245- R444); (lane 4) STEll (pNC251) mixed with 
STEllM (pNC245); (lane 5) STEUM (pNC245). (B and D] Protein extracts from transformed STE11+ stel2A (E929-6C-7) strains as 
follows: (lane 1) STEllM-R'*̂ ^ (pNC245-R444); (lane 2) STEllM (pNC245). 
conditions. Immune complex assays were performed 
with extracts prepared from cultures treated with a-
factor. The same amount of STEllM was immunopreci-
pitated from each extract (Fig. 7A). Little difference in 
STEl IM kinase activity was observed on the basis of its 
ability to phosphorylate p78 (Fig. 7B). This result sug-
gests that STEll kinase activity is not regulated by 
pheromone induction. This conclusion assumes that 
systems that may activate or inhibit STEl 1 under condi-
tions of pheromone induction do not become limiting 
with respect to the amount of STEll produced under 
control of the GAL1,10 promoter. 
We also investigated the possibility that STEll ac-
tivity as a kinase is restricted to mating-competent cell 
types. Extracts were prepared from mating-incompetent 
a/a diploid cells that overproduce the STEllM or 
STEllM-R"*^ protein. Both proteins were present in im-
mune complexes from the respective diploid cell ex-
tracts (Fig. 7C). Autoradiographs of the proteins fraction-
ated from the kinase assay showed that p78 was phos-
phorylated in reactions with the STEllM protein but 
not the inactive STEl I M R ^ protein (Fig. 7D). These re-
sults indicate that STEll kinase activity is not abso-
lutely restricted to the haploid cell type. 
STEll kinase activity is required for its functions in 
vivo 
We wished to determine whether STEll function as a 
kinase is required for both Gi arrest and the transcrip-
tional controls that are a prerequisite for mating. To 
make these tests, a MATa yeast strain with a complete 
deletion of the stell gene (E929-6C-28) was transformed 
with a centromeric plasmid that either does not express 
STEll (pNC160), that expresses the normal STEll pro-
tein (pNC193), or that expresses the catalytically inac-
tive STEll-R^ protein (pNC193-R444). The trans-
formed strains were first compared for ability to mate by 
the standard patch test. The stell^. transformed strain 
that did not express STEll (E929-6C-28 pNC160) and 
the strain that produced the STEll-R'^ protein (E929-
6C-28 pNC193-R444) were completely mating defective 
(Table 1). 
These three strains were then compared for their 
ability to become arrested in the Gi phase by treatment 
with pheromone. The culture expressing the STEll pro-
tein behaved toward pheromone in the characteristic 
fashion (Fig. 8). After a 2-hr exposure to pheromone, 
cells arrested at the Gi stage of the cell cycle, as evi-
denced by the accumulation of unbudded cells. The cul-
ture accumulated unbudded cells (80%) for 4 hr. After 
this time cells began to recover from pheromone-in-
duced arrest, and numbers of unbudded cells in the cul-
tures decreased. In contrast, the culture without any 
STEl 1 and the culture expressing the STEl 1-R'*̂  kinase 
mutation maintained the same low percentage of un-
budded cells in the culture (25-30%) throughout the 
time course of the experiment (Fig. 8). 
We made use of two different reporter genes to deter-
mine whether the STEll-R"*^ kinase mutation would 
affect STEll-dependent transcription. The recipient 
strain used for these comparisons carries the CYC7-H2 
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Figure 7. In vitro kinase activity of STEl 1 is not regulated by 
pheromone or cell type. (A and C) Immunoblots of immune 
complex kinase reactions performed with, protein extracts as 
specified below. An arrow indicates the position of the STEl IM 
and STEllM-R'*^ proteins. {B and D] Autoradiographs of im-
munoblots shown in A and C, respectively. The upper arrow 
indicates the position of the phosphorylated STEllM-R**̂  and 
STEl IM proteins; the lower arrow indicates the position of the 
phosphorylated 78-kD protein, p78. {A and B\ Protein extracts 
from transformed stell^ (E929-6C-28) strains expressing 
STEllM (pNC245) or STEllM-R'̂ ^ (pNC245-R444| proteins. 
For pheromone induction, the culture expressing the STEllM 
protein (E929-6C-28, pNC245) was treated with 5 fjiM a-factor, 
and protein extracts were prepared at indicated intervals after 
induction. (C and D) Protein extracts were from MATa/MATa 
diploid (E929-6C-32) strains expressing STEllM (pNC245) or 
STEl IM-R*^ (pNC245-R'» |̂ proteins. 
gene as a reporter for basal levels of cell-type-specific 
gene expression and the FUSl-lacZ gene as a reporter 
for pheromone-inducible gene expression. The CYC7-
H2 allele is an insertion of a Tyl element in the 5'-non-
coding region of CYC7, which is the structural gene for 
iso-2-cytochrome c. The inserted Tyl element causes iso-
2-cytochrome c expression to come under mating-type 
control and to be dependent on a functional STEll 
product (Errede et al. 1981). The STEll-R'*^ kinase mu-
tation was defective in supporting basal levels of cell-
type-specific transcription as measured by iso-2-cy-
tochrome c production from the CYC7-H2 reporter 
(Table 1). Expression of FUSl in yeast is pheromone in-
ducible, and this induction requires a fimctional STEll 
product (McCaHrey et al. 1987). The 44-bp pheromone-
inducible upstream activating sequence (UAS) from the 
PUSl gene was cloned upstream bf the Escherichia coh 
lacZ gene, which encodes |3-galactosidase. The STEll-
R'*^ kinase mutation was defective in supporting phero-
mone-inducible transcription as measured by p-galacto-
sidase activity from the PUSl -lacZ reporter (Table 1). 
The results of the above experiments show that strains 
expressing the kinase domain mutant protein were de-
fective for both pheromone-induced Gj arrest and tran-
scriptional activation functions. Because a single amino 
acid substitution that abolishes kinase activity is re-
sponsible for these defects, we conclude that STEll ki-
nase activity is crucial for each of these in vivo func-
tions. 
We also investigated the possibility that the stell-
R444 allele may have a dominant negative phenotype. A 
strain with a normal chromosomal copy of STEll (E929-
6C-16) was transformed with the centromeric plasmid 
that overproduces the catalytically inactive STEll-R''^ 
protein (pNC245-R444). There was no interference with 
mating ability in the transformed strain even though the 
STEll-R^^ protein was produced in large excess (E929-
6C-16 pNC245-R444; Table 1). The more sensitive and 
quantitative assay for pheromone-inducible expression 
of the FUSl-lskcZ reporter was also applied. A fivefold 
reduction in the amount of p-galactosidase was observed 
with extracts from the strain that overproduces the non-
functional STEll-R'^ protein (E929-6C-16 pNC245-
R444) compared with the wild-type strain without over-
production of a STEll protein (E929-6C-16). Therefore, 
it appears that the STEll-R"^ protein may partially se-
quester components that become limiting for the mating 
response. Taken together, these data indicate that the 
stell-R444 allele has only a weakly dominant negative 
phenotype. 
Discussion 
Protein phosphorylation is required for signal 
transmission and response to pheromone 
The predicted protein sequence and biochemical evi-
dence presented here support the view that STEl 1 is a 
protein kinase. On the basis of genetic criteria, STEl 1 
function is required on the pheromone-induced signal 
pathway at a point after the G protein and coincident 
with or prior to the STEl2 transcription factor (Na-
kayama et al. 1988,- Dolan and Fields 1990). It follows 
that a STEll-dependent protein phosphorylation is re-
quired for signal transmission between these two com-
ponents. There are two alternative models by which the 
STEll kinase could fulfill this role. According to one 
model, the STEll kinase could be transiently activated 
to transmit the induction signal by phosphorylation of a 
component on the pathway. In an alternative model, a 
STEll-dependent phosphorylation is a precondition for 
fimction or presence of a component that receives and 
transmits the pheromone-induced signal by a STEl 1-in-
dependent process. The immune complex assay we ap-
plied did not reveal a change in STEl 1 kinase activity 
under pheromone-inducing conditions. At face value, 
this result favors the second model for STEl 1 function 
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(ND) Not determined. 
"Mating competence (+) or mating incompetence (-) was determined by the patch test. 
••One unit corresponds to the amount of cytochrome c produced in standard cycl CYCJ-^ yeast strains. 
•̂ Units of p-galactosidase are (1000 x AA42o)/(min x mg extract). 
on the response pathway. However, an in vitro kinase 
assay could be insensitive to in vivo regulatory mecha-
nisms. Therefore, the question of whether the STEll ki-
nase transmits the pheromone-induced signal or is nec-
essary to establish the function of some other signal 
transmission component remains unresolved. 
Three other genes (STE7, KSSl, and FUS3] whose 
fimctions are implicated in the mating signal pathway 
have protein sequences predicting that they encode pro-
tein kinases. So far, STEl 1 is the only one for which bio-
chemical evidence of a protein phosphorylation function 
has been provided. Each of the four kinases is likely to 
have a different role in the response pathway. On the 
basis of the phenotype of null mutants, it is clear that 
the activity of the KSSl kinase is required for recovery 
from pheromone-induced Gi arrest, whereas FUSS has a 
predominant role in establishing pheromone-induced Gj 
arrest. The STE7 and STEll kinases are required for 
pheromone-inducible transcription, Gj arrest, and 
mating. Even though the null mutant phenotypes are 
the same for the STE7 and STEll kinases, it is unlikely 
that the two have redundant functions. First, the se-
quences of these two kinases are significantly different. 
This would exclude the possibility that they are iso-
zymes or members of the same kinase subfamily. 
Second, we have found that the mating defect caused by 
a deletion of ste7 is not relieved by overproduction of the 
STEll kinase and vice versa (N. Rhodes and Z. Zhou, 
unpubl.). 
Possible targets for STEll kinase 
Resolution of the precise role that the STEll kinase 
plays in the signal process will be aided by identification 
of its physiological targets and a knowledge of their bio-
chemical functions. One possible physiological sub-
strate of the STEll kinase is the p78 protein that be-
comes phosphorylated in the immune complex kinase 
assay. Other protein kinases have been foimd to immu-
noprecipitate in complexes with physiologically rele-
vant polypeptides. For example, the Cdc2 kinase im-
mune precipitates in a complex with a fimctionally rele-
vant substrate (Booher et al. 1989). If p78 is a relevant 
substrate, it represents an as-yet-unidentified compo-
nent of the pheromone response pathway. The 78-kD 
mobility is too slow for the predicted size of the a-sub-
unit (54 kD), p-subtmit (47 kD), or 7-subunit (13 kD) of 
G-protein, the STE7 protein kinase (55 kD), or the FUSS 
kinase (40 kD) (Teague et al. 1986; Dietzel and Kurjan 
1987; Miyajima et al. 1987; Whiteway et al. 1989; Elion 
et al. 1990). The 78-kD mobility is faster than that ob-
served for the STEll (116 kD) or STE5 (115 kD) polypep-
tides (B. Errede, impubl.; M. Hasson, R. Freedman, J. 
Schultz, and J. Thomer, in prep.). Even though none of 
the known components of the response pathway was 
implicated as a target of STEl 1 by the immune complex 
assay, some of these are logical candidates. For example, 
the STEl2 transcription factor, the STE7 kinase, and the 
STE5 protein are each phosphoproteins (B. Errede, un-
publ.; Z. Zhou, unpubl.; M. Hasson, R. Freedman, J. 







Figure 8. Pheromone-induced Gj arrest. Cultures of exponen-
tially growing E929-6C-20 cells carrying plasmids pNC160 (•), 
pNC193 (•), or pNC193-R444 (D) were treated with a-factor (5 
JJIM). Aliquots were removed at appropriate intervals, and the 
percentage of unbudded cells was determined. 
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Materials and methods 
DNA sequence determinations 
The STEll DNA sequence was determined by the chain-termi-
nation method according to "shotgun cloning" and sequencing 
procedures (Sanger et al. 1977; Bankier and Barrell 1983). DNA 
sequence data were assembled using DBSYSTEM programs on a 
VAX-11/780 computer (Staden 1982). In several regions, data 
for only one strand were obtained from the random cloning and 
sequencing strategy. Specific oligonucleotides were synthesized 
and used as sequencing primers for completion of the DNA se-
quence on both strands. 
Plasmids 
The STEll centromeric plasmids pNC192 (Fig. IB) and 
pNC193 were constructed by cloning the 4.6-kb BamHl-Xhol 
fragment (b) from pSTEll.l (Fig. lA) into the BamHl-Sall sites 
of the yeast shuttle vectors pNC160 and pNC161, respectively 
(Chaleff and Tatchell 1985; Rhodes et al. 1990). Fragment b in-
cludes the STEll gene and promoter sequences. The pNC192 
and pNC193 plasmids are identical except that the STEll gene 
is in opposite orientations in relation to the M13 origin of repli-
cation on the vector. The two plasmids allow single-stranded 
DNA to be obtained for either the coding or noncoding strands 
of STEll. A construction was made with the GALl.lO pro-
moter to allow overproduction of the STEll protein. A 685-bp 
£coRI-BflmHI fragment containing the GAL1,10 promoter 
from pBMlSO was cloned into the EcoKi-BamHl site of 
pNC160 (Johnston and Davis 1984; Rhodes et al. 1990). The 
Hindlll site in the polylinker of the vector was destroyed by 
end-repair with Klenow polymerase and religation. The STEll 
gene was cloned into the BflmHI(end-repaired)-SpiiI site of this 
vector as the AccI(end-repaired)-Spi2l fragment (c) (Fig. lA). 
The resulting plasmid is designated pNC251 (Fig. IB). 
The plasmids pNC203 and pNC202 carry the stellA6 and 
stell-M:: URA3 alleles, respectively. Construction of 
pNC203 involved the following steps. The STEll 3'-flanking 
region was isolated as the 1-kb Pstl-Cial(end-repaired) frag-
ment (e) from pSTEll.l (Fig. lA) and cloned into the Pstl-
Accl(end-repaired) sites in pUC119 (Vieiria and Messing 1987). 
This fragment was transferred as a Sphl-BamHl fragment into 
the Sphl-BamHl sites in pNC98 (Company and Errede 1987). 
The STEll 5'-flanking region was isolated as the 1.3-kb 
BamHI(end-repaired)- Hindlll fragment (f) from pSTEll.l (Fig. 
lA) and cloned into the HindIII(end-repaired)-£coRI sites of the 
previous construction. The 1.2-kb end-repaired-Hindlll frag-
ment containing the URA3 gene from pLG669-Z was isolated 
and cloned into the Hpal site of pNC203 to give pNC202 
(Guarente and Ptashne 1981). All end-repair steps were accom-
plished by filling in of 5' overhanging ends with Klenow poly-
merase. 
The YRp7MATa plasmid used for MAT gene replacement 
was provided by K. Tatchell and has been described (Tatchell et 
al. 1981). The FUSl-lacZ reporter gene was provided by G. 
Ammerer on the integrating plasmid pGA1716. An oligonu-
cleotide with Zhol-compatible ends and a sequence cone-
sponding to the FUSl UAS (nucleotide positions 3036-3074; 
Tmeheart et al. 1987) was inserted into the Xhol site of 
pLGA178 (Guarente et al. 1984). To give the integrating 
plasmid pGAl 716, sequences encompassing the 2-|xm origin of 
replication were deleted by digestion with Hindlll and religa-
tion. 
All plasmid constructions and DNA manipulations were per-
formed as described (Maniatis et al. 1982). Enzymes were pur-
chased from U.S. Biochemicals, New England Biolabs, and Be-
thesda Research Labs. 
Site-directed mutagenesis 
Two STEll frameshift mutations were constructed. A single 
base pair insertion at STEll nucleotide position 100 and a 
single base pair deletion of STEll nucleotide position 377 were 
generated with mutagenic oligonucleotides STE11.26 and 
STE11.23, respectively (Table 2). pNC193 single-stranded DNA 
served as template for each of the mutagenesis reactions. The 
respective products of the mutagenesis were designated 
pNC193.100 and pNC193.377. The mutations were confirmed 
by DNA sequence determinations using the corresponding se-
quencing primers STE11.27 and STE11.18 (Table 2). 
A fusion of the entire ST£I1-coding sequence with an oligon-
ucleotide encoding the myc epitope tag (EQKLISEEDLN) was 
constructed by site-directed mutagenesis. The oligonucleotide 
used to insert the epitope-coding sequences (STE 11.39; Table 2) 
includes the last four codons of STEll (nucleotide positions 
2255-2266), 11 codons for the peptide tag followed by the 
STEll stop codon and 3'-noncoding sequences (nucleotide po-
sitions 2267-2280). Single-stranded DNA from pNC192 served 
as the template for oligonucleotide-primed DNA synthesis. The 
insertion of the epitope-encoding sequences was confirmed by 
DNA sequence determination using oligonucleotide STE 11.40 
(Table 2) as the sequencing primer. The resulting construction 
is designated pNC212 (Fig. IB). pNC245 carries the STEll-myc 
fusion under control of the GAll,10 promoter. pNC245 was 
constructed by inserting the Ncol-SphI fragment (d) (Fig. lA) 
from pNC212 into the Ncol-Sphl site of pNC251 (Fig. IB). 
A lysine (amino acid position 444) to arginine substitution in 
the kinase catalytic domain of STEl 1 was constructed by use of 
mutagenic oligonucleotide STEl 1.29 (Table 2). pNC193 single-
stranded DNA served as template for the mutagenesis reaction. 
The product of the mutagenesis reaction was designated 
pNC193-R444. The substitution mutation was confirmed by 
DNA sequence determination using the oligonucleotide primer 
STEl 1.30 (Table 2). The substitution mutation under control of 
the GALl.lO promoter (pNC245-R444) was constructed by 
cloning the 1.0-kb Hizidlll-JVcoI fragment (g) (Fig. lA) from 
pNC193-R444 into the Hifldlll-Ncol site of pNC245 (Fig. IB). 
Oligonucleotides (Table 2) for these studies were made by au-
tomated synthesis at the oligonucleotide facility in the Depart-
ment of Pathology at the Univerity of North Carolina. Single-
stranded template DNA was produced by the method of Kunkel 
(1985) with the addition of the helper phage M13K07 (Vieira 
and Messing 1987). Mutagenic oligonucleotides were annealed 
to the template, and second strand synthesis was performed as 
described (Zoller and Smith 1982). The resulting double-
stranded DNA was transformed into E. coli strain DH5aF' (Be-
thesda Research Laboratories). The desired mutations were 
identified by DNA sequence of random £. coli isolates. The 
phenotype of at least two independent isolates for each muta-
tion was tested in yeast. 
Yeast genetic procedures 
The LiCl procedure was used for yeast transformations (Ito et 
al. 1983). Gene replacements were performed according to the 
method of Rothstein (1983). Unless specified, media and ge-
netic procedures were as described in Sherman et al. (1979). 
Pheromone inductions were performed by use of a-factor 
(synthesized in the UNCCH-NIEHS Protein Chemistry Lab) at 
a final concentration of 5 |xM in medium that was buffered to 
pH 4.5 as described (Fink and Styles 1972). Pheromone-induced 
Gi arrest was assayed by using exponentially growing cells ex-
posed to a-factor. Aliquots were removed at appropriate in-
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Table 2. Oligonucleotides 








































"Mutagenic base(s) are underlined. (N) A mixture of the four nucleotides. 
(̂ +) Coding strand of STEl 1; (-) noncoding strand. 
«=Numbers indicate positions in the STEl 1 gene. 
tervals and fixed in 5% formaldehyde, and cells were scored 
under a microscope as budded or unbudded. At least 200 indi-
vidual cells were scored for each culture. 
Mating competence was scored by the patch test (Sprague and 
Herskowitz 1981). 
Yeast strains 
The strain E929-6C (MATa cycl, CYC7-H2, canl, leu2-3,112, 
trpl-M, ura3-52] was used for the construction of the isogenic 
derivatives described below. The strains KZ8-1D (MATa 
cycl-1, CYC7, his4, mal] and KZ8-5C (MATa cycl-1, CYC7, 
his4, mal ] were used as tester strains for determining mating 
phenotypes. 
The stell deletion strain E929-6C-5 {stell-A6 :: URA3] was 
constructed from E929-6C by use of the 2.6-kb Xbal fragment 
from pNC202 for gene replacement. A second stell deletion 
strain without the URA3 marker, E929-6C-20 [stell-A6], was 
constructed from E929-6C-5 by use of the 1.4-kb Xbal fragment 
from pNC203 for gene replacement. The stell-A6 :: URA3 al-
lele in E929-6C-5 and stell-A6 allele in E929-6C-20 were con-
firmed by Southern blot analysis. Strains with the FUSl-lacZ 
reporter gene, E929-6C-16 [STEll^ FUSl-lacZ] and E929-6C-
28 {stell-A6 FUSl-lacZ] were constructed from E929-6C and 
E929-6C-20, respectively, by integration of pGA1716. The 
plasmid pGA1716 was linearized with Apal to target its inte-
gration to the uia3-52 locus of the respective recipient strains. 
The diploid strain E929-6C-32 (MATa/MATa LYS2*/lys2] was 
made by crossing strain E929-6C to E929-6C-15 (MATa lys2]. 
First, an isogenic MATa derivative of E929-6C was constructed 
by gene replacement using the 4.2-kb HindlU MATa fragment 
from the plasmid YRp7MATa. A Lys" derivative of this MATa 
strain was selected on a-aminoadipate (Chattoo and Sherman 
1979). The lesion causing the Lys" phenotype was shown to be 
a lys2 mutation by complementation analysis with a known 
lys2 strain. Construction of the stel2 deletion strain E929-6C-7 
[STEll^ stel2-M :: URA3] has been described (Company and 
Errede 1988). 
RNA analyses 
RNA was prepared from cultures of E929-6C and E929-6C-20 in 
YPD medium. Cultures were grown to a density of 1 x 10'' to 
2 X 107 cells/ml at 30°C. RNA from pheromone-induced cells 
was prepared from E929-6C cultures in buffered YPD medium 
that had been exposed to 5 |JLM a-factor for 2 hr (Fink and Styles 
1972). Total RNA was prepared according to the glass-bead lysis 
and extraction method (Broach et al. 1979). 
Probe DNA for SI protection analysis was prepared either 
with oligonucleotide STE11.75 or oligonucleotide STE11.18 
(Table 2). The oligonucleotides were end-labeled using polynu-
cleotide kinase and [-/-̂ ^PlATP. The labeled primers were an-
nealed to pNC193 template DNA and extended with Klenow 
polymerase. In the case of STEl 1.75, a 200-nucleotide probe 
was obtained by digestion with Hindlll. In the case of STEl 1.18, 
a 1.1-kb nucleotide probe was obtained by digestion with Kpnl. 
The probe DNAs were isolated from their corresponding mix-
tures after fractionation on a denaturing polyacrylamide gel 
(Dretzen et al. 1981). SI nuclease reactions were performed ac-
cording to established procedures (Greene and Struhl 1987). 
The size of the protected fragments was determined by electro-
phoresis on 8% denaturing polyacrylamide gels. A reference 
DNA sequence ladder was provided by DNA sequence reaction 
products obtained with pNC193 template DNA and the appro-
priate ^^P-end-labeled primer (McGraw 1984). 
Prepaiation of yeast protein extracts 
Cultures requiring selection of plasmids were grown to mid-log 
phase in selective medium. Other cultures were grown in com-
plete synthetic medivun. Galactose (2%) was used as the carbon 
source where overproduction of the STEll protein reqviired in-
duction of the GAL1,10 promoter. Pheromone (a-factor)-in-
duced cultures were grown as described above with aliquots of 
the same culture taken at various intervals after treatment with 
a-factor. Protein extracts were prepared as described by Com-
pany et al. (1988). A 40% ammonium sulfate fraction was used 
for the experiments presented in this work. All protein concen-
trations were determined by use of the Bio-Rad protein assay 
reagent kit. 
Immunoprecipitations and kinase assays 
Immunoprecipitations and kinase assays were performed as de-
scribed by Celenza and Carlson (1989). For our purpose, 500 jig 
of protein extract was incubated with 10 (xg of the mouse 
monoclonal antibody Mycl-9E10 at 4°C (Evan et al. 1985). The 
antibody—protein complexes were precipitated by adsorption to 
Staphylococcus aureus cells (Sigma) or protein A-Sepharose 
beads (Sigma). The kinase assays were performed directly on 
the washed, adsorbed immune complexes by incubation with 
kinase assay buffer in the presence of [y-^^V]ATV. After the reac-
tion, proteins were released from the adsorbed complex by 
boiling in SDS-PAGE buffer, fractionated by SDS-PAGE, and 
transferred to nitrocellulose. The nitrocellulose filters were 
subjected to immunoblot analysis for detection of immunopre-
cipitated proteins prior to autoradiography (see below). 
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Immunoblot analysis 
Whole-cell extracts or immune-precipitated proteins were frac-
tionated on a 10% SDS-polyacrylamide gel and electroblotted 
onto nitrocellulose paper (Laemmli 1970; Towbin et al. 1979). 
The Mycl-9E10 antibody (2 ixg/ml) was used to detect the elec-
troblotted STEllM and STEllM-R'*^ proteins. The Promega 
Protoblot immunoblotting system with goat anti-mouse IgG 
conjugated to alkaline phosphatase (0.1 |xg/ml) was used to de-
tect the primary antibody by colorimetric methods. Immuno-
blotting and color development were performed according to 
procedures provided with the Promega Protoblot system. 
Assays for zepoiter gene products 
Enzymatic activity of p-galactosidase was measured by use of 
whole-cell protein extracts prepared 3 hr after induction with 
a-factor. Approximately 10̂  cells were pelleted and washed 
with 1 ml of Z buffer (60 mM Na2HP04, 40 niM NaH2P04, 10 
mM KCl, 1 mM MgClj, 50 mM 2-mercaptoethanol) containing 1 
mM phenylmethylsulfonyl fluoride (PMSF) (Miller 1982). The 
washed cells were suspended in 200 yul of Z buffer with 1 mM 
PMSF. Cells were lysed by vigorous vortexing with glass beads 
(0.45-0.50 |xm diameter) for 8 min at 4°C. The supernatant 
from a 5-min centrifugation was removed to a clean tube, and 
protein concentration was determined. The p-galactosidase 
assays were performed by use of 10 |xg of protein extract in 120 
|xl of Z buffer containing 2.2 mM O-nitrophenyl-3-D-galacto-
pyranoside. The change in absorbance at 420 nm with time was 
followed using a V â̂  kinetic microtiter plate reader (Molecular 
Devices). 
The relative amount of iso-2-cytochrome c was determined 
spectroscopically from intact yeast cells that had been grown 
under derepressed conditions for cytochrome c content (Errede 
etal. 1981). 
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